Walleye Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4
Closed -$103 4509
2025
Q3
$103 Sell
4
-176
-98% -$6.65K ﹤0.01% 4397
2025
Q2
$10.3K Buy
+180
New +$14.4K ﹤0.01% 4306
2025
Q1
Sell
-5,056
Closed -$240K 4178
2024
Q4
$240K Sell
5,056
-3,264
-39% -$197K ﹤0.01% 3615
2024
Q3
$817K Buy
8,320
+3,764
+83% +$486K ﹤0.01% 2847
2024
Q2
$745K Buy
4,556
+1,292
+40% +$184K ﹤0.01% 3127
2024
Q1
$498K Buy
3,264
+1,912
+141% +$318K ﹤0.01% 3201
2023
Q4
$424K Sell
1,352
-472
-26% -$171K ﹤0.01% 3080
2023
Q3
$810K Buy
+1,824
New +$824K ﹤0.01% 2432

Other funds holding AGL

Walleye Capital's AGL Position: Q2 2026 in Review

Walleye Capital opened a new position in Agilon Health (AGL) in Q2 2026: 15,440 shares worth $1.65M. The stake represents 0.01% of the portfolio and ranks #1691 among its holdings. This is a return to the name: Walleye Capital previously reported a position in AGL as recently as Q3 2025.

Walleye Capital first reported a position in AGL in Q4 2021 and has held it in 8 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Walleye Capital held 15,440 shares of Agilon Health worth $1.65M as of Q2 2026.
  • Agilon Health was a new Walleye Capital position in Q2 2026.
  • Agilon Health made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1691 holding.
  • Walleye Capital first reported a position in Agilon Health in Q4 2021 and has held it in 8 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.